The forecast for hospital discharges due to malignant neoplasm of the uterus in Canada shows a gradual decline from 6.48 thousand in 2024 to 6.05 thousand by 2028. This indicates a consistent downward trend over these years. Considering the data from 2023 was not provided, we cannot calculate the precise year-on-year percentage variations for 2023 to 2024. However, the cumulative annual growth rate (CAGR) across 2024 to 2028 suggests a manageable decrease in hospital discharges, reflecting improvements in prevention or early diagnosis.
Future trends to watch for include advancements in medical technologies, such as diagnostic tools and treatment techniques, as well as public health initiatives focused on prevention and early detection. These factors may further influence the downward trend in hospitalizations for uterine cancer.
